Greenwich LifeSciences, Inc. Share Price
NASDAQ: GLSI | Micro CapGreenwich LifeSciences, Inc. Stock Performance
Greenwich LifeSciences, Inc. Share Price Today
As of 18 September 2026, Greenwich LifeSciences, Inc.'s share price is $19.13. The stock opened at $18.63, compared to its previous close of $18.52. During today's trading session, Greenwich LifeSciences, Inc.'s share price traded between $18.63 and $18.77, with an average price of $18.70. Over the past 52 weeks, the stock has recorded a high of $33.91 and a low of $7.83. In terms of performance, Greenwich LifeSciences, Inc.'s share price has declined by 20.38% over the last six months and is up 94.56% on a year-on-year basis.
Greenwich LifeSciences, Inc. Share Price Chart
Greenwich LifeSciences, Inc. Quarterly Profit & Loss
All figures in USD
Greenwich LifeSciences, Inc. Annual Profit & Loss
All figures in USD
About Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Greenwich LifeSciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $14.59 | $18.77 | +1.76% |
Aug 2026 | $13.75 | $18.44 | +39.27% |
Jul 2026 | $24.27 | $13.24 | -43.95% |
Jun 2026 | $28.11 | $23.62 | -10.67% |
May 2026 | $24.32 | $26.44 | +13.38% |
Apr 2026 | $24.38 | $23.32 | -2.91% |
Mar 2026 | $27.99 | $24.02 | -14.12% |
Feb 2026 | $30.65 | $27.97 | -5.44% |
Jan 2026 | $20.55 | $29.58 | +39.27% |
Dec 2025 | $8.60 | $21.24 | +144.14% |
Nov 2025 | $8.91 | $8.70 | -5.33% |
Oct 2025 | $9.98 | $9.19 | -6.51% |